期刊文献+

肝素诱导血小板减少症2例 被引量:2

Heparin-induced thrombocytopenia:two case reports
原文传递
导出
摘要 例1为24岁男性患者,因急性心肌梗死,给予阿司匹林300mg、氯吡格雷300mg口服和普通肝素10000U静脉推注,并行冠状动脉造影、经皮冠状动脉腔内成形术及支架植入术。患者术前血小板计数为228.0×10~9/L,术后1h降至36.2×10~9/L。考虑为肝素诱导的血小板减少,遂停用肝素,给予阿加曲班0.5~2μg·kg^(-1)·min^(-1)静脉滴注。第3天患者血小板升至101×10~9/L,第4天恢复正常。例2为69岁男性冠状动脉粥样硬化性心脏病患者,在冠状动脉造影术中静脉推注普通肝素3000U。之后,行冠状动脉搭桥术,术前连续7d给予低分子肝素(1mg·kg^(-1)·12h^(-1))皮下注射,术中给予普通肝素7000U静脉滴注。术前患者血小板计数197.0×10~9/L,术后降至19.2×10~9/L。停用肝素,给予阿加曲班0.5~1.5μg·kg^(-1)·min^(-1)静脉滴注,血小板计数升至146.0×10~9/L。 Patient 1, a 24-year-old man, received aspirin 300 mg, clopidogrel 300 mg, and an IV push of heparin 10 000 U , then he underwent coronary arteriography, percutaneous transluminal angioplasty and stenting for acute myocardial infarction. His platelet count was 228.0 ×10^9/L before surgery. One hour after surgery, his platelet count decreased to 36.2×10^9/L. Heparin-induced thrombocytopenia was considered. Subsequently, heparln was discontinued, and an IV infusion of argatroban 0.5-2μg·kg-1·min-1 was given. On day 3, the patient's platelet count increased to 101 ×10^9/L and, on day 4, the platelet count returned to normal range. Patient 2, a 69-year-old man, with coronary atherosclerotic cardiopathy received an IV push of heparin 3000 U during coronary arteriography. Subsequently, he underwent coronary bypass. SC low-molecular-weight heparin 1 mg · kg-1 · 12 h-1 was given for 7 days before surgery and an IV infusion of heparin 7000 U was given during surgery. His platelet count was 197 ×10^9/L before surgery and decreased to 19.2×10^9/L after surgery. Heparin was stopped and an IV infusion of argatroban 0.5-1.5μg·kg-1·min-1 was given. His plateht count increased to 146.0 ×10^9/L.
出处 《药物不良反应杂志》 2011年第3期186-187,共2页 Adverse Drug Reactions Journal
关键词 肝素 血小板减少症 肺栓塞 heparin thrombocytopenia pulmonary embolism
  • 相关文献

参考文献6

  • 1Warkentin TE. Management of heparin-induced thrombo- cytopenia: a critical comparison of lepirudin and argatro- ban[J]. Thromb Res, 2003, 110(2-3) :73-82.
  • 2Martel N, Lee J, Wells PS. Risk for heparin-indueed thrombocytopenia with unfractionated and low-molecular- weight heparin thromboprophylaxis : a meta-analysis [ J ]. Blood, 2005, 106(8): 2710-2715.
  • 3Warkentin TE, Sheppard JA, Sigouin CS, et al. Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia [ J ]. Blood, 2006, 108 ( 9 ) : 2937- 2941.
  • 4Lo GK, Juhl D, Warkentin TE, et al. Evaluation of pre- test clinical score (4T's) for the diagnosis of heparin-in- duced thrombocytopenia in two clinical settings [ J ]. J Thromb Haemost, 2006, 4(4) : 759-765.
  • 5Bounameaux H. Contemporary management of pulmonary embolism : the answers to ten questions [ J ]. J Intern Med, 2010, 268(3) :218-231.
  • 6Warkentin TE, Greinacher A, Koster A, et al. Treatment and prevention of heparin-induced thrombocytopeuia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines ( 8th Edition) [ J ]. Chest, 2008,133 (6 Suppl) :340S-380S.

同被引文献21

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部